Pages that link to "Q78109126"

The following pages link to Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins (Q78109126):

Displaying 25 items.

• Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways (Q24562820) (← links)
• Prognostic molecular markers in early breast cancer (Q24794845) (← links)
• The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone (Q24796330) (← links)
• Estrogen receptor transcription and transactivation: Basic aspects of estrogen action (Q24800814) (← links)
• The normal and malignant mammary gland: a fresh look with ER beta onboard (Q28245988) (← links)
• Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland (Q28590461) (← links)
• Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response (Q33254067) (← links)
• Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients (Q33775528) (← links)
• Antiestrogens--tamoxifen, SERMs and beyond (Q33832651) (← links)
• The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens (Q33856027) (← links)
• Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance (Q33903965) (← links)
• Estrogen receptors and proliferation markers in primary and recurrent breast cancer (Q33953032) (← links)
• Is there a growing role for endocrine therapy in the treatment of breast cancer? (Q33993658) (← links)
• Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters (Q35786187) (← links)
• Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer (Q35793341) (← links)
• PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients (Q35821415) (← links)
• Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells (Q36509058) (← links)
• Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer (Q36622650) (← links)
• Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? (Q36622899) (← links)
• EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions (Q36623198) (← links)
• Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity (Q37106891) (← links)
• Estrogen receptors alpha and beta in the rodent mammary gland (Q37152373) (← links)
• Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium. (Q55025944) (← links)
• Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use (Q57142597) (← links)
• ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis (Q57292242) (← links)